Iodine seed prostate brachytherapy: an alternative first-line choice for early prostate cancer
Open Access
- 8 June 2004
- journal article
- review article
- Published by Springer Science and Business Media LLC in Prostate Cancer and Prostatic Diseases
- Vol. 7 (3), 201-207
- https://doi.org/10.1038/sj.pcan.4500727
Abstract
This article on permanent iodine-125 seed prostate brachytherapy reviews the techniques, results, and patient selection issues for early prostate cancer. The long-term 10 y results of brachytherapy from Seattle, and their reproducibility in other centres both in the USA and UK are reported. The use of hormone therapy in brachytherapy and the value of combining external beam radiotherapy with a brachytherapy implant are discussed. Reviewed comparative data show the similarity of biochemical survival in patients treated with brachytherapy, radical prostatectomy, and external beam radiotherapy. The role of brachytherapy as a first-line treatment option for patients with prostate cancer is demonstrated.Keywords
This publication has 54 references indexed in Scilit:
- Importance of implant dosimetry for patients undergoing prostate brachytherapyUrology, 2003
- Ten-year biochemical relapse-free survival after external beam radiation and brachytherapy for localized prostate cancer: the Seattle experienceInternational Journal of Radiation Oncology*Biology*Physics, 2003
- 1???125 Versus Pd-103 for Low-Risk Prostate CancerThe Cancer Journal, 2002
- 10-year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 2001
- The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinomaRadiotherapy and Oncology, 2000
- Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Isotope selection for patients undergoing prostate brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinomaCancer, 1998
- Long-Term Results of Retropubic Permanent 125 Iodine Implantation of the Prostate for Clinically Localized Prostatic CancerJournal of Urology, 1997
- Transperineal 125 Iodine Seed Implantation in Prostatic Cancer Guided by Transrectal UltrasonographyJournal of Urology, 1983